RxDoctor Payments Data

Nancy Shina, NP

Nurse Practitioner · Ogden, UTNPI 1255884037

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.2% of the total across 258 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 32.1% of the total. Among nurse practitioner clinicians in UT with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,269in general payments, 2019–2025

Across 258 payments — averaging $16.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novartis$598
  • Regeneron Healthcare Solutions, Inc.$442
  • Sun Pharmaceutical Industries Inc.$431
  • Johnson & Johnson$378
  • Biofrontera Inc.$314
  • plus $737 from 12 others

What the payments were for

  • Food & beverage$3,89491%
  • Education$3759%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,269 in reported general payments places this provider in the 90th percentile of 979 nurse practitioner providers in Utah.

See all nurse practitioner providers in Utah

Medicare billing

Part B allowed, 2024
$217,833
Medicare patients
497
Services billed
10,747

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab11$74,080
Acitretin12$2,356
Fluorouracil31$2,088
Ketoconazole75$1,256
Clobetasol Propionate16$1,165
Doxycycline Monohydrate111$1,080
Metronidazole13$629
Triamcinolone Acetonide45$591
ValacyclovirValacyclovir Hcl24$512
Imiquimod11$346
Cephalexin45$250
Hydrocortisone19$241
Ciprofloxacin Hcl32$116
Doxycycline Hyclate11$73

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Ogden

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →